These occurrences commonly take place in the initial weeks of treatment, notably as the dosage escalates
Novo Nordisk, Ozempic and Wegovy's manufacturer, told NBC News last week the company is still experiencing supply chain issues that will last through the month, though access to some dosages of Ozempic for patients with Type 2 diabetes has improved
Seven additional Phase 3 readouts expected through 2026: TRIUMPH-1 (obesity), TRIUMPH-2 (obesity + diabetes), TRIUMPH-3 (obesity + cardiovascular risk), SELECT-M (MASH), SLEEP (OSA), BACK PAIN, and a cardiovascular/renal outcomes readout
It is also approved to reduce cardiovascular risk in adults with heart disease who have obesity or are overweight
If this is a medical emergency, please call 911 or visit the nearest hospital.